Literature DB >> 2956881

Huntington disease in Maryland: clinical aspects of racial variation.

S E Folstein, G A Chase, W E Wahl, A M McDonnell, M F Folstein.   

Abstract

In a Maryland survey of Huntington disease, the prevalence in blacks was unexpectedly high and equal to that in whites. Age at onset was earlier in blacks, and their clinical features, at all ages at onset, were similar to those seen in juvenile-onset Huntington disease. Blacks had more severe bradykinesia and abnormalities of eye movement and less frequent psychiatric disorder, particularly depression.

Entities:  

Mesh:

Year:  1987        PMID: 2956881      PMCID: PMC1684204     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  27 in total

1.  Neurological disease in Uganda.

Authors:  P W HUTTON
Journal:  East Afr Med J       Date:  1956-06

2.  Abnormal ocular motor control in Huntington's disease.

Authors:  R J Leigh; S A Newman; S E Folstein; A G Lasker; B A Jensen
Journal:  Neurology       Date:  1983-10       Impact factor: 9.910

3.  A polymorphic DNA marker genetically linked to Huntington's disease.

Authors:  J F Gusella; N S Wexler; P M Conneally; S L Naylor; M A Anderson; R E Tanzi; P C Watkins; K Ottina; M R Wallace; A Y Sakaguchi
Journal:  Nature       Date:  1983 Nov 17-23       Impact factor: 49.962

4.  The measurement of abnormal movement: methods developed for Huntington's disease.

Authors:  S E Folstein; B Jensen; R J Leigh; M F Folstein
Journal:  Neurobehav Toxicol Teratol       Date:  1983 Nov-Dec

Review 5.  Psychiatric features of Huntington's disease: recent approaches and findings.

Authors:  S E Folstein; M F Folstein
Journal:  Psychiatr Dev       Date:  1983

6.  Huntington's Chorea in the Netherlands. The problem of genetic heterogeneity.

Authors:  L N Went; M Vegter-van der Vlis; G W Bruyn; W S Volkers
Journal:  Ann Hum Genet       Date:  1983-07       Impact factor: 1.670

7.  A genetic model for age at onset in Huntington disease.

Authors:  L A Farrer; P M Conneally
Journal:  Am J Hum Genet       Date:  1985-03       Impact factor: 11.025

8.  Lifetime prevalence of specific psychiatric disorders in three sites.

Authors:  L N Robins; J E Helzer; M M Weissman; H Orvaschel; E Gruenberg; J D Burke; D A Regier
Journal:  Arch Gen Psychiatry       Date:  1984-10

9.  Huntington's disease: two families with differing clinical features show linkage to the G8 probe.

Authors:  S E Folstein; J A Phillips; D A Meyers; G A Chase; M H Abbott; M L Franz; P G Waber; H H Kazazian; P M Conneally; W Hobbs
Journal:  Science       Date:  1985-08-23       Impact factor: 47.728

10.  The diagnosis of Huntington's disease.

Authors:  S E Folstein; R J Leigh; I M Parhad; M F Folstein
Journal:  Neurology       Date:  1986-10       Impact factor: 9.910

View more
  27 in total

Review 1.  Neuropsychiatry of the basal ganglia.

Authors:  H A Ring; J Serra-Mestres
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-01       Impact factor: 10.154

2.  Huntington's Disease.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-05       Impact factor: 3.598

Review 3.  Huntington's disease: a decade beyond gene discovery.

Authors:  Penelope Hogarth
Journal:  Curr Neurol Neurosci Rep       Date:  2003-07       Impact factor: 5.081

4.  Longitudinal behavioral, cross-sectional transcriptional and histopathological characterization of a knock-in mouse model of Huntington's disease with 140 CAG repeats.

Authors:  Aaron C Rising; Jia Xu; Aaron Carlson; Vincent V Napoli; Eileen M Denovan-Wright; Ronald J Mandel
Journal:  Exp Neurol       Date:  2010-12-28       Impact factor: 5.330

5.  Epidemiological and linkage studies on Huntington's disease in Italy.

Authors:  M Frontali; P Malaspina; C Rossi; A G Jacopini; G Vivona; M S Pergola; A Palena; A Novelletto
Journal:  Hum Genet       Date:  1990-07       Impact factor: 4.132

Review 6.  Huntington's disease: the coming of age.

Authors:  Mritunjay Pandey; Usha Rajamma
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

7.  Modified electroconvulsive therapy for the treatment of refractory schizophrenia-like psychosis associated with Huntington's disease.

Authors:  Takeshi Nakano; Shinji Ono; Junji Yamaguchi; Ryu Sugimoto; Naohiro Yamaguchi; Yoshiro Morimoto; Tatsuya Kubo; Hiroki Ozawa; Naohiro Kurotaki
Journal:  J Neurol       Date:  2012-10-25       Impact factor: 4.849

8.  Behavioral Changes in Huntington Disease

Authors:  Jason Brandt
Journal:  Cogn Behav Neurol       Date:  2018-03       Impact factor: 1.600

9.  Irritability in pre-clinical Huntington's disease.

Authors:  Stefan Klöppel; Cynthia M Stonnington; Predrag Petrovic; Dean Mobbs; Oliver Tüscher; David Craufurd; Sarah J Tabrizi; Richard S J Frackowiak
Journal:  Neuropsychologia       Date:  2009-10-28       Impact factor: 3.139

10.  Secondary psychoses: an update.

Authors:  Matcheri S Keshavan; Yoshio Kaneko
Journal:  World Psychiatry       Date:  2013-02       Impact factor: 49.548

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.